Category Archives: The Basics

You are here:

Home
Category "The Basics"

Chronic Lymphocytic Leukemia (CLL), Ibrutinib and Fungal Infections

Sad news. CLL Society just lost a member due to a fatal fungal blood infection that was not identified until the...

July 16, 2021ComplicationsBy Brad Hedrick

ASH 2020: Dr. Furman Discusses Minimal Residual Disease-Driven Captivate and Murano Studies in Chronic Lymphocytic Leukemia (CLL)

The treatment landscape for those of us with CLL/SLL has changed dramatically in the past decade or less. We see...

June 24, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick

ASH 2020: Dr. Paolo Ghia on the Benefits of Individualized Treatment Plans for Chronic Lymphocytic Leukemia (CLL)

At the annual meeting of the American Society of Hematology (ASH) 2020, our own Dr. Brian Koffman interviewed Dr. Paolo...

June 17, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick

Introduction to Immunity

All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection...

June 11, 2021The BasicsBy Brad Hedrick

ASH 2020: Dr. Jennifer Woyach on Triple Combination Therapy for Chronic Lymphocytic Leukemia (CLL)

Bruton’s tyrosine kinase (BTK) inhibitors such as ibrutinib and acalabrutinib have been wonderfully effective drugs for treating chronic lymphocytic leukemia...

June 2, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick

White Blood Cells and Differential for CLLers

All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection...

March 22, 2021The BasicsBy Brad Hedrick

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Testing in Patients with Chronic Lymphocytic Leukemia (CLL)

At the American Society of Hematology’s (ASH) 2020 conference, there was research on looking at the genome of CLL and...

March 11, 20212020 Conferences, Test Before TreatBy Brad Hedrick

Testing for Measurable (Minimal) Residual Disease (MRD) in CLL (Chronic Lymphocytic Leukemia) Down to One in One Million Cells Just Got Easier

Flow cytometry is the standard test to look for Measurable (Minimal) Residual Disease (MRD) in CLL and it can find...

March 1, 2021MRD & Disease MonitoringBy Brad Hedrick

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat

Recorded Thursday, February 4, 2021 Resources Virtual Exhibit Resources Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test...

February 6, 2021hidden, Test Before TreatBy Brad Hedrick

ASH 2020: Dr. William Wierda on minimal residual disease (MRD)-guided discontinuation of ibrutinib + venetoclax in chronic lymphocytic leukemia (CLL)

ASH 2020: Dr. William Wierda on minimal residual disease (MRD)-guided discontinuation of ibrutinib + venetoclax in chronic lymphocytic leukemia (CLL)...

January 29, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick